TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2019

Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.

Ran Reshef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.